Related Experiment Videos
Cerebral ischemia in 5-lipoxygenase knockout mice
Kazuo Kitagawa1, Masayasu Matsumoto, Masatsugu Hori
1Division of Strokology, Department of Internal Medicine and Therapeutics (A8), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan. kitagawa@medone.med.osaka-u.ac.jp
Brain Research
|March 23, 2004
Summary
Cerebral ischemia involves 5-lipoxygenase but leukotriene production does not significantly expand infarct size. Studies using 5-lipoxygenase knockout mice found no difference in brain damage from ischemia.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Cerebral ischemia, a condition of reduced blood flow to the brain, triggers the activation of 5-lipoxygenase (5-LO).
- This enzyme is involved in the production of leukotrienes, signaling molecules implicated in inflammatory processes.
Purpose of the Study:
- To investigate the pathological role of 5-lipoxygenase in cerebral ischemia.
- To determine if leukotriene production contributes to brain damage and infarct expansion following ischemic events.
Main Methods:
- Utilized 5-lipoxygenase knockout mice and wild-type littermates for comparative studies.
- Induced both permanent and transient focal cerebral ischemia for 60 minutes in the experimental models.
- Assessed and compared the infarct size between the knockout and wild-type groups post-ischemia.
Main Results:
- No significant differences in infarct size were observed between 5-lipoxygenase knockout mice and wild-type mice after permanent or transient cerebral ischemia.
- These findings indicate that the absence of 5-lipoxygenase does not alter the extent of brain damage in this model.
Conclusions:
- The study does not support the hypothesis that leukotriene production by 5-lipoxygenase plays a significant role in infarct expansion in focal cerebral ischemia.
- Further research may be needed to explore other inflammatory pathways or mechanisms involved in ischemic brain injury.